Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldblatt

Showing results (221-230 of 242) with videos related to

Pageof 25
Sort By:
Nature Genetics|February 11, 2014
Dense genomic sampling identifies highways of pneumococcal recombinationClaire Chewapreecha, Simon R Harris, Nicholas J Croucher, et al.
American Journal of Respiratory and Critical Care Medicine|February 2, 2013
Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adultsDaniela M Ferreira, Daniel R Neill, Mathieu Bangert, et al.
Biorxiv : the Preprint Server for Biology|January 12, 2022
Comprehensive antibody profiling of mRNA vaccination in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
The Lancet. HIV|April 29, 2021
Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trialAdriana Weinberg, Petronella Muresan, Lauren Laimon, et al.
The Lancet. Infectious Diseases|January 31, 2021
Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trialEd Clarke, Adedapo Bashorun, Ikechukwu Adigweme, et al.
Science Translational Medicine|July 26, 2022
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
Vaccine|October 9, 2022
Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisationAsia-Sophia Wolf, Elena Mitsi, Scott Jones, et al.
The New England Journal of Medicine|September 27, 2024
Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority TrialKatherine E Gallagher, Ruth Lucinde, Christian Bottomley, et al.
Infection and Immunity|November 16, 2011
RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodiesCarole Harfouche, Sara Filippini, Claudia Gianfaldoni, et al.
Lancet (London, England)|June 13, 2006
Pneumococcal vaccination in developing countriesOrin S Levine, Katherine L O'Brien, Maria Knoll, et al.
Pageof 25

Showing results (221-230 of 242) with videos related to

Sort By:
Pageof 25
Nature Genetics|February 11, 2014
Dense genomic sampling identifies highways of pneumococcal recombinationClaire Chewapreecha, Simon R Harris, Nicholas J Croucher, et al.
American Journal of Respiratory and Critical Care Medicine|February 2, 2013
Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adultsDaniela M Ferreira, Daniel R Neill, Mathieu Bangert, et al.
Biorxiv : the Preprint Server for Biology|January 12, 2022
Comprehensive antibody profiling of mRNA vaccination in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
The Lancet. HIV|April 29, 2021
Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trialAdriana Weinberg, Petronella Muresan, Lauren Laimon, et al.
The Lancet. Infectious Diseases|January 31, 2021
Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trialEd Clarke, Adedapo Bashorun, Ikechukwu Adigweme, et al.
Science Translational Medicine|July 26, 2022
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
Vaccine|October 9, 2022
Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisationAsia-Sophia Wolf, Elena Mitsi, Scott Jones, et al.
The New England Journal of Medicine|September 27, 2024
Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority TrialKatherine E Gallagher, Ruth Lucinde, Christian Bottomley, et al.
Infection and Immunity|November 16, 2011
RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodiesCarole Harfouche, Sara Filippini, Claudia Gianfaldoni, et al.
Lancet (London, England)|June 13, 2006
Pneumococcal vaccination in developing countriesOrin S Levine, Katherine L O'Brien, Maria Knoll, et al.
Pageof 25